ArticleBioengineering (Basel, Switzerland)2024
ViT-PSO-SVM: Cervical Cancer Predication Based on Integrating Vision Transformer with Particle Swarm Optimization and Support Vector Machine.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Application of artificial intelligence in cervical cytology: a systematic review of deep learning models, datasets, and reported metrics.Frontiers in big data · 2025Pooled it
- Deep neural architecture empowered by explainable artificial intelligence for accurate and early diagnosis of gynaecological cancer using medical images.Scientific reports · 2026Article
- Explainable artificial intelligence with pyramid vision transformer model for multi-class malignant cell classification on cytology slides.Scientific reports · 2026Article
- Artificial intelligence for colposcopic and cytological image analysis in early cervical cancer detection.iScience · 2026Review
- Forecasting photovoltaic power in high-latitude regions via support vector machine optimized by meta-heuristics.Scientific reports · 2026Article
- Artificial intelligence-driven screening, early diagnosis, and treatment strategies for cervical cancer: an overview.Infectious agents and cancer · 2025Review
- Liver Cancer: Artificial Intelligence (AI)-Based Integrated Therapeutic Approaches.Bioengineering (Basel, Switzerland) · 2025Article
- A hybrid compound scaling hypergraph neural network for robust cervical cancer subtype classification using whole slide cytology images.Scientific reports · 2025Article
- Advances in AI Technology in Healthcare.Bioengineering (Basel, Switzerland) · 2025Article
- Leveraging swin transformer with ensemble of deep learning model for cervical cancer screening using colposcopy images.Scientific reports · 2025Article
- Automated detection of pinworm parasite eggs using YOLO convolutional block attention module for enhanced microscopic image analysis.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer (CCa) is the fourth most prevalent and common cancer affecting women worldwide, with increasing incidence and mortality rates. Hence, early detection of CCa plays a crucial role in improving outcomes. Non-invasive imaging procedures with good diagnostic performance are desirable and have the potential to lessen the degree of intervention associated with the gold standard, biopsy. Recently, artificial intelligence-based diagnostic models such as Vision Transformers (ViT) have shown promising performance in image classification tasks, rivaling or surpassing traditional convolutional neural networks (CNNs). This paper studies the effect of applying a ViT to predict CCa using different image benchmark datasets. A newly developed approach (ViT-PSO-SVM) was presented for boosting the results of the ViT based on integrating the ViT with particle swarm optimization (PSO), and support vector machine (SVM). First, the proposed framework extracts features from the Vision Transformer. Then, PSO is used to reduce the complexity of extracted features and optimize feature representation. Finally, a softmax classification layer is replaced with an SVM classification model to precisely predict CCa. The models are evaluated using two benchmark cervical cell image datasets, namely SipakMed and Herlev, with different classification scenarios: two, three, and five classes. The proposed approach achieved 99.112% accuracy and 99.113% F1-score for SipakMed with two classes and achieved 97.778% accuracy and 97.805% F1-score for Herlev with two classes outperforming other Vision Transformers, CNN models, and pre-trained models. Finally, GradCAM is used as an explainable artificial intelligence (XAI) tool to visualize and understand the regions of a given image that are important for a model's prediction. The obtained experimental results demonstrate the feasibility and efficacy of the developed ViT-PSO-SVM approach and hold the promise of providing a robust, reliable, accurate, and non-invasive diagnostic tool that will lead to improved healthcare outcomes worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.